GLP-1 medicines and the brain: early Alzheimer signals

You may have seen headlines saying weight-loss and diabetes shots could also protect the brain and fight Alzheimer's disease. That is an exciting idea, and there is real science behind it. But the story is not finished yet. GLP-1 medicines, such as semaglutide and liraglutide, were first made to control blood sugar and help with weight. Now researchers are studying whether they also help the brain. Some small and medium trials have shown promising signals, like slower memory decline and less brain shrinkage. But the biggest trials so far did not show a clear clinical benefit, and no GLP-1 medicine is approved to treat or prevent dementia. This guide explains the biology, what the trials really found, and what it means for you, in plain words. Please talk to your doctor about your own situation.